The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Revises Stance on Testosterone Therapy: Implications Renew Vitality Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law The FDA's Current Position on Peptides Explained Holt Law In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few